Home › Funds › NEXT CENTURY GROWTH INVESTORS LLC › ADPT

NEXT CENTURY GROWTH INVESTORS LLC position in ADPT

ADAPTIVE BIOTECHNOLOGIES COR · Health Care

NEXT CENTURY GROWTH INVESTORS LLC reported holding 622,894 shares of ADPT (ADAPTIVE BIOTECHNOLOGIES COR) in its Q3 2026 13F filing — a position valued at US$18.0M, representing 1.15% of its reported portfolio and ranking #33 among its reported holdings. NEXT CENTURY GROWTH INVESTORS LLC has disclosed ADPT holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)622.89K sh
Reported value held$18.00M
Portfolio Weight1.15%
First reportedQ3 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How NEXT CENTURY GROWTH INVESTORS LLC's ADPT position evolved

NEXT CENTURY GROWTH INVESTORS LLC first disclosed a stake in ADPT in Q3 2025 at 531,317 shares (US$7.9M). The position peaked in Q3 2026 at 622,894 shares, worth US$18.0M. Across 5 filings, NEXT CENTURY GROWTH INVESTORS LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 622,894 shares valued at US$18.0M — an increase of 13,064 shares quarter over quarter.. Notable position changes include a 78% increase in Q4 2025 (shares fell 15% over the following quarter), a 47% trim in Q1 2026 (shares rose 55% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 531.32K $7.95M New
Q4 2025 943.60K $15.32M Add
Q1 2026 504.35K $7.00M Reduce
Q2 2026 609.83K $13.08M Add
Q3 2026 622.89K $18.00M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ADPT and 13F data

ADPT (ADAPTIVE BIOTECHNOLOGIES COR) is a Health Care company. 57 other funds we track also report a position in ADPT — the largest reported positions include Viking Global Investors (US$643.4M), VIKING GLOBAL INVESTORS LP (US$643.4M), Aristotle Atlantic Partners, LLC (US$39.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ADPT

All ADPT fund holders →

FAQ

How long has NEXT CENTURY GROWTH INVESTORS LLC held ADPT?

NEXT CENTURY GROWTH INVESTORS LLC has disclosed ADPT holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is NEXT CENTURY GROWTH INVESTORS LLC's current position in ADPT?

As of Q3 2026, NEXT CENTURY GROWTH INVESTORS LLC holds 622.89K shares of ADPT (ADAPTIVE BIOTECHNOLOGIES COR), valued at $18.00M, representing 1.15% of its reported portfolio and ranking #33.

Has NEXT CENTURY GROWTH INVESTORS LLC been buying or selling ADPT?

In the latest 13F filing (Q3 2026), NEXT CENTURY GROWTH INVESTORS LLC increased its position in ADPT. The position peaked in Q3 2026 at 622.89K shares.

Which other funds hold ADPT?

Other major institutional holders of ADPT include Viking Global Investors, VIKING GLOBAL INVESTORS LP, Aristotle Atlantic Partners, LLC, among 57 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.